Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03288948 · ClinicalTrials.gov registry record · NA
Binocular Amblyopia Treatment
A NA study of Amblyopia, sponsored by Retina Foundation of the Southwest.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT03288948 is a NA study of Amblyopia that is actively recruiting participants, run by Retina Foundation of the Southwest. The registered enrollment target is 120 participants, below the 161-participant average among 24 other Amblyopia trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03288948, a NA study of Amblyopia, is actively recruiting participants, sponsored by Retina Foundation of the Southwest.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the effectiveness of enhanced binocular amblyopia treatments in achieving a more complete and stable recovery.
Conditions Studied
Interventions
- OTHER Binocular games for treatment of amblyopia
Study Locations (1)
Texas
- Retina Foundation of the Southwest - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2017-08-31 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03288948
The ClinicalTrials.gov registry entry for NCT03288948 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 161-participant average among 24 other Amblyopia trials with a reported enrollment target (25% lower). The listed sponsor is Retina Foundation of the Southwest, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 1 intervention - of which Binocular games for treatment of amblyopia is the first listed.
NCT03288948 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03288948 about?
NCT03288948 is a clinical study titled "Binocular Amblyopia Treatment". To evaluate the effectiveness of enhanced binocular amblyopia treatments in achieving a more complete and stable recovery.
What is the current status of trial NCT03288948?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2017-08-31. Estimated completion is 2026-12-31.
What conditions does trial NCT03288948 study?
This clinical trial studies the following conditions: Amblyopia.
What interventions are being tested in trial NCT03288948?
The interventions under investigation include: Binocular games for treatment of amblyopia (OTHER).
Who is sponsoring clinical trial NCT03288948?
This trial is sponsored by Retina Foundation of the Southwest, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03288948 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amblyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Noninvasive Brain Stimulation in Adult Amblyopia
RECRUITING · NA
-
OCT Eccentric Fixation and Amblyopia in Children
RECRUITING · NA
-
Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games
RECRUITING · NA
-
Patch-free Occlusion Therapy
RECRUITING · NA
-
Amblyopia Treatment for Children Aged 8 to 12 Years
RECRUITING · NA
-
Novel Amblyopia Treatment With Virtual Reality Games
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.